Latest & greatest articles for HIV Test

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on HIV Test or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on HIV Test and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for HIV Test

181. Economic evaluation of HIV testing among intravenous drug users

Economic evaluation of HIV testing among intravenous drug users Economic evaluation of HIV testing among intravenous drug users Economic evaluation of HIV testing among intravenous drug users Villari P, Fattore G, Siegel J E, Paltiel A D, Weinstein M C Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment (...) Italian Lire (L1,000 = US$0.60 @ May 1995). Sensitivity analysis Sensitivity analyses have been carried out on epidemiological (mortality ratio for IVDUs, probability of viral transmission - as a marker of risk of infection - and EIA sensitivity) and economic variables (costs of AIDS and symptomatic HIV-positive IVDUs treatment and follow-up, screening costs and discount rates) to test the incremental cost-effectiveness ratio. Estimated benefits used in the economic analysis The incremental life years

1996 NHS Economic Evaluation Database.

182. Counseling and testing for HIV prevention: costs, effects, and cost-effectiveness of more rapid screening tests

Counseling and testing for HIV prevention: costs, effects, and cost-effectiveness of more rapid screening tests Counseling and testing for HIV prevention: costs, effects, and cost-effectiveness of more rapid screening tests Counseling and testing for HIV prevention: costs, effects, and cost-effectiveness of more rapid screening tests Farnham P G, Gorsky R D, Holtgrave D R, Jones W K, Guinan M E Record Status This is a critical abstract of an economic evaluation that meets the criteria (...) for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology New rapid human HIV antibody test. Type of intervention Diagnosis, primary prevention. Economic study type Cost-effectiveness analysis. Study population Hypothetical cohort of the general population. Setting Primary care. The economic study was carried out in the USA. Dates to which

1996 NHS Economic Evaluation Database.

183. The cost-effectiveness of HIV testing of physicians and dentists in the United States

The cost-effectiveness of HIV testing of physicians and dentists in the United States The cost-effectiveness of HIV testing of physicians and dentists in the United States The cost-effectiveness of HIV testing of physicians and dentists in the United States Phillips K A, Lowe R A, Kahn J G, Lurie P, Avins A L, Ciccarone D Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods (...) , the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Human immunodeficiency testing(HIV) testing of physicians and dentists. Type of intervention Primary prevention. Economic study type Cost-effectiveness analysis and cost-benefits analysis. Study population Hypothetical cohort of physicians and dentists. Setting Hospital or diagnostic centres. The economic study was carried out in the USA. Dates to which data

1994 NHS Economic Evaluation Database.

184. The cost-effectiveness of voluntary counseling and testing of hospital inpatients for HIV infection

The cost-effectiveness of voluntary counseling and testing of hospital inpatients for HIV infection The cost-effectiveness of voluntary counseling and testing of hospital inpatients for HIV infection The cost-effectiveness of voluntary counseling and testing of hospital inpatients for HIV infection Lurie P, Avins A L, Phillips K A, Kahn J G, Lowe R A, Ciccarone D Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract (...) contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Voluntary counselling and testing of hospital inpatients for HIV infection. Type of intervention Diagnosis. Economic study type Cost-effectiveness analysis. Study population US hospital inpatients. Setting Hospital. The economic study was carried out in California, USA. Dates to which data relate The analysis

1994 NHS Economic Evaluation Database.